Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) stock closed at $3.88 on 12/19/24 after a major increase of 12.1%. Moreover, this advance was accompanied by exceptionally high trading volume at 242% of normal. The stock has risen 5.1% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Ironwood Pharmaceuticals is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment